Bristol-Myers Squibb

Bristol Myers Squibb’s Phase III CheckMate -816 trial hit the primary endpoint in an interim analysis evaluating the company’s checkpoint inhibitor Opdivo (nivolumab) and chemotherapy in patients with resectable stage IB to IIIA non-small cell lung cancer.

A cheap and widely used steroid called dexamethasone has become the first drug shown to be able to save lives among COVID-19 patients in what scientists said is a “major breakthrough” in the coronavirus pandemic.

The cancer treatment Imfinzi was shown to prolong survival in a particularly aggressive type of lung cancer by close to three months in a late-stage clinical trial, as AstraZeneca holds the British drugmaker’s ground in a crowded field against rival immunotherapy drugs.